Cabazitaxel for the treatment of castration-resistant prostate cancer.
about
The role of abiraterone in the management of metastatic castration-resistant prostate cancer.The role of enzalutamide in the treatment of castration-resistant prostate cancer.(-)-Rhazinilam and the diphenylpyridazinone NSC 613241: Two compounds inducing the formation of morphologically similar tubulin spirals but binding apparently to two distinct sites on tubulin.
P2860
Cabazitaxel for the treatment of castration-resistant prostate cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Cabazitaxel for the treatment of castration-resistant prostate cancer.
@en
type
label
Cabazitaxel for the treatment of castration-resistant prostate cancer.
@en
prefLabel
Cabazitaxel for the treatment of castration-resistant prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Cabazitaxel for the treatment of castration-resistant prostate cancer.
@en
P2093
Guru Sonpavde
Neeraj Agarwal
Oliver Sartor
P2860
P356
10.2217/FON.10.168
P407
P577
2011-01-01T00:00:00Z